Overall rank by patents
#36,496
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES).
The verdict
Mercy holds 7 US patents across 10 technology areas, rank #36,496 of 50,000 tracked assignees.
Mercy Medical Research Institute has been granted 7 US utility patents between 2015 and 2018, placing Mercy Medical Research Institute at rank #36,496 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES). As a US Corporation, Mercy Medical Research Institute is one of the more focused assignees in the PatentsView dataset. By volume, Mercy sits between Meiragtx UK II Limited (7 patents, rank #36,492) and Metacure Limited (7 patents, rank #36,500) - the closest US assignees by grant volume. The composite Innovation Score of 27.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 7 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mercy Medical Research Institute's 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mercy Medical Research Institute against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MeiraGTX UK II Limited
7 patents
Melchor Gabilondo, S.A.
7 patents
Menlo Microsystems, Inc.
7 patents
Menlo Systems GmbH
7 patents
Meril Life Sciences PVT LTD
7 patents
Meritage Pharma, Inc.
7 patents
Mesa Digital, LLC
7 patents
MetaCure Limited
7 patents
Mercy Medical Research Institute
7 patents
What this shows Mercy holds 7 patents at rank #36,496, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,496 in granted patent volume.
Other assignees with the most granted patents in Mercy's primary technology class.
Mercy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2016 | 2 | 28.6% |
| 2017 | 3 | 42.9% |
| 2018 | 1 | 14.3% |
Top 10 of 10 technology areas
Overall rank by patents
#36,496
Across all tracked assignees
27.1 out of 100
How to use this portfolio
Mercy's 7 grants land it in the top 78% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.